TREA

John Andrew Christopher

Follow

Person

  • Welwyn Garden City, GB
People

Patents Grantslast 30 patents

  • Information Patent Grant

    CGRP antagonist compounds
    • Patent number 12,344,621
    • Issue date Jul 1, 2025
    • Nxera Pharma UK Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Orexin 1 receptor antagonists
    • Patent number 12,331,029
    • Issue date Jun 17, 2025
    • Nxera Pharma UK Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Oxexin 1 receptor antagonists
    • Patent number 12,240,825
    • Issue date Mar 4, 2025
    • Nxera Pharma UK Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 12,178,813
    • Issue date Dec 31, 2024
    • Nxera Pharma UK Limited
    • John Andrew Christopher
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine...
    • Patent number 11,680,053
    • Issue date Jun 20, 2023
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine...
    • Patent number 11,584,732
    • Issue date Feb 21, 2023
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
    • Patent number 10,981,889
    • Issue date Apr 20, 2021
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 10,888,561
    • Issue date Jan 12, 2021
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
    • Patent number 10,584,111
    • Issue date Mar 10, 2020
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Orexin receptor antagonists
    • Patent number 10,316,028
    • Issue date Jun 11, 2019
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 10,300,056
    • Issue date May 28, 2019
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 10,259,812
    • Issue date Apr 16, 2019
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
    • Patent number 10,246,432
    • Issue date Apr 2, 2019
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 10,166,226
    • Issue date Jan 1, 2019
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 9,925,178
    • Issue date Mar 27, 2018
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Orexin receptor antagonists
    • Patent number 9,850,237
    • Issue date Dec 26, 2017
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 9,808,457
    • Issue date Nov 7, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 9,802,935
    • Issue date Oct 31, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CGRP receptor antagonists
    • Patent number 9,688,660
    • Issue date Jun 27, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
    • Patent number 9,676,745
    • Issue date Jun 13, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Orexin receptor antagonists
    • Patent number 9,555,044
    • Issue date Jan 31, 2017
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Orexin receptor antagonists
    • Patent number 9,249,160
    • Issue date Feb 2, 2016
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    PEPTIDE DERIVATIVES AND RELATED USES AS OREXIN AGONISTS
    • Publication number 20240360175
    • Publication date Oct 31, 2024
    • Centessa Pharmaceuticals (UK) Limited
    • Noel Michael O'BOYLE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    2-(3-ETHYNYLBENZYL)-SUBSTITUTED HETEROCYCLE DERIVATIVES AND RELATED...
    • Publication number 20240239744
    • Publication date Jul 18, 2024
    • Orexia Therapeutics Limited
    • John Andrew CHRISTOPHER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    SARS-COV-2 MPRO INHIBITOR COMPOUNDS
    • Publication number 20240217930
    • Publication date Jul 4, 2024
    • HEPTARES THERAPEUTICS LIMITED
    • Miles Stuart CONGREVE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
    • Publication number 20240092754
    • Publication date Mar 21, 2024
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SARS-COV-2 MPRO INHIBITOR COMPOUNDS
    • Publication number 20240083845
    • Publication date Mar 14, 2024
    • HEPTARES THERAPEUTICS LIMITED
    • Miles Stuart CONGREVE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CGRP ANTAGONIST COMPOUNDS
    • Publication number 20220306651
    • Publication date Sep 29, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OXEXIN 1 RECEPTOR ANTAGONISTS
    • Publication number 20220098165
    • Publication date Mar 31, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
    • Publication number 20220056009
    • Publication date Feb 24, 2022
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OREXIN 1 RECEPTOR ANTAGONISTS
    • Publication number 20220041573
    • Publication date Feb 10, 2022
    • Heptares Therapeutics Limited
    • Giles Albert Brown
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
    • Publication number 20210309632
    • Publication date Oct 7, 2021
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP RECEPTOR ANTAGONISTS
    • Publication number 20210213011
    • Publication date Jul 15, 2021
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OX1 ANTAGONISTS
    • Publication number 20210179578
    • Publication date Jun 17, 2021
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
    • Publication number 20200172505
    • Publication date Jun 4, 2020
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP RECEPTOR ANTAGONISTS
    • Publication number 20190231773
    • Publication date Aug 1, 2019
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
    • Publication number 20190177297
    • Publication date Jun 13, 2019
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OREXIN RECEPTOR ANTAGONISTS
    • Publication number 20180370961
    • Publication date Dec 27, 2018
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP Receptor Antagonists
    • Publication number 20180153876
    • Publication date Jun 7, 2018
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CGRP Receptor Antagonists
    • Publication number 20180015085
    • Publication date Jan 18, 2018
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CGRP Receptor Antagonists
    • Publication number 20180009808
    • Publication date Jan 11, 2018
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
    • Publication number 20170275265
    • Publication date Sep 28, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP Receptor Antagonists
    • Publication number 20170239236
    • Publication date Aug 24, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    OREXIN RECEPTOR ANTAGONISTS
    • Publication number 20170121320
    • Publication date May 4, 2017
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP RECEPTOR ANTAGONISTS
    • Publication number 20170121311
    • Publication date May 4, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP Receptor Antagonists
    • Publication number 20170121331
    • Publication date May 4, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CGRP Receptor Antagonists
    • Publication number 20170121348
    • Publication date May 4, 2017
    • Heptares Therapeutics Limited
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OREXIN RECEPTOR ANTAGONISTS
    • Publication number 20160213678
    • Publication date Jul 28, 2016
    • Heptares Therapeutics Limited
    • Miles Stuart Congreve
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS
    • Publication number 20160145236
    • Publication date May 26, 2016
    • HEPTARES THERAPEUTICS LIMITED
    • John Andrew Christopher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    OREXIN RECEPTOR ANTAGONISTS
    • Publication number 20150126498
    • Publication date May 7, 2015
    • Miles Stuart Congreve
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Indole Derivatives and Use Thereof as Kinase Inhibitors in Particul...
    • Publication number 20080269200
    • Publication date Oct 30, 2008
    • SmithKline Beecham Corporation
    • Ian Robert Baldwin
    • C07 - ORGANIC CHEMISTRY